ICU Corporation
ICU Corporation is a South Korean private optometry company operating the ICU Vision Care retail brand, providing precision eye exams, custom progressive lens design, and branded eyewear to children and adult consumers across five South Korean centers, while developing pediatric strabismus digital therapeutics for global launch.
- Company typePrivate
- Founded2018
- HeadquartersGyeongsan, South Korea
- Headcount11–50
- GTM typeB2C
- OfferingServices
What ICU Corporation does
ICU Corporation (주식회사 아이씨유코퍼레이션) is a South Korean private company that operates the ICU Vision Care retail optometry brand, founded by CEO and optometrist Kim Dong-hyuk. The original ICU Vision Care eye examination center was established in 2018 with a focus on pediatric eye examinations and vision management, and the legal entity was incorporated in 2022. The company operates company-owned retail optometry centers plus a franchise channel, currently totaling five locations in South Korea (Changwon headquarters, Busan Myeongji, Unicty in Gwangju, and two franchise sites in Daegu).
The company's core service offering combines precision optometry examinations performed by nationally certified optometrists with custom in-house progressive multifocal lens design, using high-end optical equipment such as ZEISS VISUFIT 1000 and ZEISS I-PROFILER rather than relying on automated lens company designs. It serves two primary customer segments: children and adolescents requiring specialized care for myopia, strabismus, amblyopia, and anisometropia, and general adult consumers seeking accurate prescriptions and premium eyewear. Retail product offerings include lenses from ZEISS and HOYA, frames from OAKLEY, IZIPIZI, WEWE, Maison Margiela, and Carven, and contact lenses from Bausch & Lomb, CooperVision, and Alcon.
ICU generates revenue through three streams: professional eye examination services, eyewear and contact lens product sales, and franchise fees. Beyond retail, the company has an active R&D pipeline that includes a pediatric strabismus digital therapeutic targeting FDA approval and global launch, plus a VR-based strabismus training system (patent registered 2025), positioning it as a developer of medical device and digital therapeutic products as well as an optometry retailer. The stated long-term ambition is to operate 100 ICU Vision Care centers globally by 2028, contingent on regulatory milestones and franchise scaling.
ICU Corporation firmographics
Firmographics- Name
- ICU Corporation
- Legal name
- 주식회사 아이씨유코퍼레이션
- Website
- https://icuvc.kr
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ICU Corporation is a South Korean private optometry company operating the ICU Vision Care retail brand, providing precision eye exams, custom progressive lens design, and branded eyewear to children and adult consumers across five South Korean centers, while developing pediatric strabismus digital therapeutics for global launch.
- Ownership category
- akta.pro rank
ICU Corporation industry classification
Industry- Product category
- Optometry and Vision Care Services
- NAICS
- Offices of Optometrists (62132), Optical Goods Retailers (45613)
- SIC
- Ophthalmic Goods (3851)
- akta.pro industry
- Optometry Clinics (Primary Eye Care)Contact Lens Specialty & Myopia ControlContact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions)Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment)Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)Ocular Imaging & Diagnostic Testing Centers
Keywords
Where ICU Corporation is headquartered
LocationHeadquarters
- HQ city
- Gyeongsan
- HQ country
- South Korea
- HQ region
- Asia
Offices5 records
Markets served
ICU Corporation business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Franchise Fees: ICU Vision Care operates company-owned centers and also franchises the brand to external operators. Franchise centers include Daegu Gyeongsan Center (opened 2023) and Daegu Suseong Center (opened 2023).
- Eyewear Product Sales: Sale of eyeglass frames and lenses. Carries multiple branded eyewear products including lenses (ZEISS, HOYA), frames (OAKLEY, IZIPIZI, WEWE, 2FACE, Maison Margiela, Carven), and contact lenses (Bausch & Lomb, CooperVision, Alcon).
- Professional Eye Examination Services: Provides comprehensive eye examination services including age and environment-adjusted precision optometry, myopia/astigmatism/hyperopia management, strabismus treatment, amblyopia optical therapy, and anisometropia prism adjustment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Custom eye examination and eyewear services |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels5 records
ICU Corporation product offering
Product offeringCore offering
ICU Corporation (operating as ICU Vision Care) operates precision optometry centers providing age- and environment-adjusted eye examinations, myopia/astigmatism/hyperopia management, strabismus and amblyopia treatment, and custom-designed progressive multifocal lenses using ZEISS VISUFIT 1000 and other advanced optical equipment. The company also retails branded eyewear (frames, lenses, contact lenses) from ZEISS, HOYA, OAKLEY, IZIPIZI, WEWE, Maison Margiela, Carven, Bausch & Lomb, CooperVision, and Alcon through company-owned and franchised centers in South Korea, and is developing digital therapeutics for pediatric strabismus.
Product overview
ICU Corporation operates a unified vision care platform combining retail eyewear sales with specialized optometry services and digital therapeutics. The core business model integrates: (1) vision examination and management services including pediatric myopia control and strabismus treatment; (2) custom progressive multifocal lens design using proprietary equipment; (3) retail sale of branded eyewear including HOYA and ZEISS lenses, OAKLEY sports goggles, WEWE children's eyewear, and IZIPIZI sunglasses; and (4) digital therapeutics products including a pediatric strabismus digital treatment and VR-based vision training system. The company currently operates multiple vision care centers in South Korea with plans to expand internationally.
Differentiator
Problem solved
Functional benefit
Brands
- 사시 및 사위 트레이닝 시스템: VR-based digital therapeutic system for strabismus and stereo vision training
- 소아 사시 디지털 치료제
Quantifiable outcome
- High adaptation success rate through custom progressive lens design vs. standard automated lens design
Companies that use ICU Corporation
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
ICU Corporation technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
ICU Corporation partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- 인제대학교 - 부산백병원 (Inje University - Busan Paik Hospital)coreMOU for business cooperation signed in 2025. Represents an academic-medical partnership for clinical research and development in ophthalmology and optometry.
- 대구가톨릭대학교 약학과 / 물리치료학과 / 안경광학과 (Daegu Catholic University)coreMOU signed in 2021 with Daegu Catholic University's pharmacy, physical therapy, and optometry departments for academic cooperation and talent development.
- 초록우산 어린이재단 (Green Umbrella Children's Charity)coreVision donation project partnership signed in 2021 with Green Umbrella Children's Charity, providing eye exams and eyewear to children in protection facilities.
- ZEISS (Carl Zeiss)coreGerman optical technology leader. ZEISS VISUFIT 1000 and ZEISS I-PROFILER equipment used for precision eye measurements and custom lens design. Official brand partner.
- HOYAcoreWorld-leading optical lens brand. HOYA lenses offered as part of the eyewear product portfolio. Official brand partner.
Scale indicators4 records
Recent moves11 records
Expansion highlights6 records
ICU Corporation competitors and assessment
Company assessmentRegional players
- Gentle Monster: South Korea-based premium eyewear and lifestyle brand with global flagship stores and design-led positioning. Comparable to ICU as a Korean-origin eyewear brand competing on brand and design, though with a fashion rather than clinical optometry focus.
- Davich Optical (다비치안경): One of the largest optical retail chains in South Korea with hundreds of stores offering prescription eyewear, lenses, and contact lenses. Highly comparable to ICU as a direct competitor in Korean precision optometry retail with overlapping product categories (ZEISS/HOYA lenses, branded frames).
Emerging players
- Luminopia: US-based digital therapeutics company that received FDA approval for Luminopia One, a digital therapeutic for pediatric amblyopia (lazy eye). Comparable to ICU as a digital-therapeutic player in pediatric vision disorders pursuing FDA pathways overlapping with ICU's strabismus/amblyopia pipeline.
- NovaSight: Israel-based pediatric vision technology company developing eye-tracking-based digital treatments for amblyopia and other binocular vision disorders. Comparable to ICU as a competing pediatric-vision digital therapeutics developer pursuing similar clinical indications.
Broad incumbents
- LensCrafters (EssilorLuxottica): Global optical retail chain owned by EssilorLuxottica, offering prescription eyewear and eye exams with proprietary lens brands. Comparable to ICU as a global premium optical retailer that uses in-house lens brands and competes for premium eye-care positioning.
- Specsavers: Global optical and audiology retail chain operating thousands of stores with in-house optometrists and clinical service focus. Comparable to ICU as a precision-optometry-led, multi-country optical retailer that pairs clinical exams with eyewear sales.
- OWNDAYS: Asia-Pacific optical retailer operating hundreds of stores across Japan, Korea, and Southeast Asia, with a 30-minute same-day eyeglasses model. Comparable to ICU as a scaled Asian optical retail competitor expanding through owned retail in overlapping South Korean markets.
- JINS: Japan-headquartered global eyewear retailer with significant presence in South Korea, known for in-house brand eyewear at accessible price points and omnichannel retail. Comparable to ICU as a multi-country optical retail chain competing for the same Korean consumer eye-care wallet.
Direct peers
- Lenskart: India-headquartered tech-enabled eyewear retailer with proprietary brands, in-store digital measurements, and aggressive omnichannel expansion across Asia. Comparable to ICU as a tech-forward, vertically integrated optical retailer pursuing tech-enabled precision fitting and rapid multi-market expansion.
- Warby Parker: US-based vertically integrated eyewear retailer combining prescription eyewear, eye exams, and proprietary brands via DTC and physical stores. Comparable to ICU as a precision-optometry-meets-direct-retail hybrid operating in higher-service, brand-driven optical retail.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks1 record
Key highlights7 records
Customer concentration
ICU Corporation social profiles
Digital presenceICU Corporation compliance and trust
Trust signalCompliance3 records
ICU Corporation financial estimates
Financial estimateRevenue estimate
Valuation estimate
ICU Corporation leadership team
Management profileNumber of profiles
Profiles1 record
ICU Corporation funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ICU Corporation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ICU Corporation
What does ICU Corporation do?
ICU Corporation (operating as ICU Vision Care) operates precision optometry centers providing age- and environment-adjusted eye examinations, myopia/astigmatism/hyperopia management, strabismus and amblyopia treatment, and custom-designed progressive multifocal lenses using ZEISS VISUFIT 1000 and other advanced optical equipment. The company also retails branded eyewear (frames, lenses, contact lenses) from ZEISS, HOYA, OAKLEY, IZIPIZI, WEWE, Maison Margiela, Carven, Bausch & Lomb, CooperVision, and Alcon through company-owned and franchised centers in South Korea, and is developing digital therapeutics for pediatric strabismus.
Is ICU Corporation a public or private company?
ICU Corporation is a private company. It is classified as venture growth investor backed and is currently operating.
When was ICU Corporation founded?
ICU Corporation was founded in 2018. It employs 11 to 50 people.
Where is ICU Corporation based?
ICU Corporation is headquartered in Gyeongsan, South Korea, in the Asia region.
How does ICU Corporation make money?
Three revenue lines are on record. Franchise Fees are the primary driver. The others are eyewear Product Sales and professional Eye Examination Services.
Who are ICU Corporation's main competitors?
Regional players on record are Gentle Monster and Davich Optical (다비치안경). Emerging players are Luminopia and NovaSight. Broad incumbents are LensCrafters (EssilorLuxottica), Specsavers, OWNDAYS and JINS. Direct peers are Lenskart and Warby Parker.
Does ICU Corporation have an API?
No public API is recorded for ICU Corporation.
What industry is ICU Corporation in?
ICU Corporation's product category is Optometry and Vision Care Services. Its primary akta.pro industry code is HLAKAKAB, Optometry Clinics (Primary Eye Care), with a secondary code of HLAKAKAK, Contact Lens Specialty & Myopia Control. Its NAICS code is 62132 and its SIC code is 3851.